Press Releases Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 08:20:08 15/01/26 pm AEDT			5-day change	1st Jan Change
41.39 ^EUR	-0.68%		+5.13%	+12.31%

15/01	German DAX Index Slips; Bayer, RWE Shares Surge	MT
15/01	Frankfurt Stocks Close: DAX Ends Impressive Record-Breaking Streak	DP

Press Releases

14/01	Bayer Accelerates Pharma Growth on High-Value Portfolio	BU
14/01	Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause	BU
13/01	Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus	BU
13/01	Bayer : to expand into molecular imaging with acquisition of innovative pan-amyloid radiotracers from Attralus	PU
08/01	Bayer : to launch innovative strawberry variety	PU
08/01	Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy	BU
06/01	Bayer : receives Breakthrough Therapy Designation in the U.S. and China for sevabertinib as a first-line treatment for patients with HER2-mutant non-small cell lung cancer	PU
06/01	Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference	BU
05/01	Bayer : to present updates on pharma growth strategy and pipeline advancements at J.P. Morgan’s 44th Annual Healthcare Conference	PU
29/12	Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
22/12	Bayer : Finerenone approved in Japan for treatment of patients with chronic heart failure	PU
19/12	Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
19/12	Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
13/12	Bayer : Aflibercept 8 mg recommended for EU approval for third retinal indication	PU
09/12	Bayer : AskBio’s AB-1005 and AB-1002 Receive Pioneering Regenerative Medical Product Designation in Japan	PU
05/12	Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
04/12	Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	EQ
04/12	Bayer : MediaBayer starts Phase IIa study for treatment of patients with Alport Syndrome	PU
04/12	Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome	BU
04/12	RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints	BU
04/12	Bayer : Data from Pediatric Study for Bayer's Investigational MRI Contrast Agent presented at RSNA 2025	PU
03/12	Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia	BU
02/12	Bayer : starts Phase III study with Mirena® (52mg LNG- IUS) for treatment of nonatypical endometrial hyperplasia	PU
02/12	Bayer : welcomes Solicitor General support for U.S. Supreme Court review	PU
02/12	Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Bayer slows after strong recovery, valuation stretched

17 December 2025 at 07:41 pm AEDT

Bayer, close to the final round(up)?

06 June 2025 at 12:56 am AEST

Roundup: Bayer ordered to pay $2.1bn to an American suffering from cancer

24 March 2025 at 09:21 pm AEDT